-
Ismagilov Lab, California Institute of Technology | Pasadena, California | United States | 24 days ago
includes development of scientific knowledge and technologies to impact human health, in particular in areas of emerging human pathogens, human host-microbe interactions, and human immune response
-
of the United States. Relocation assistance may be available based on business needs and/or eligibility. Sunshine Act Pfizer reports payments and other transfers of value to health care providers as required by federal
-
to contribute to selection of targets for progression from chemical/biologic synthesis to testing in human. Leads the creation of the clinical development plan from pre-clinical stages through to proof of concept
-
eligibility. Sunshine Act Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and
-
does not apply to Tampa, FL or any location outside of the United States. Relocation assistance may be available based on business needs and/or eligibility. Sunshine Act Pfizer reports payments and other
-
of the United States. Relocation assistance may be available based on business needs and/or eligibility. Sunshine Act Pfizer reports payments and other transfers of value to health care providers as required by federal
-
to Tampa, FL or any location outside of the United States. Relocation assistance may be available based on business needs and/or eligibility. Sunshine Act Pfizer reports payments and other transfers of value
-
; the Institute for Human Genetics and the Department of Bioengineering and Therapeutic Sciences at the University of California, San Francisco; and Lawrence Berkeley National Lab. The Brenner Research Group is